Influence of botulinum toxin on myogenous facial pain

被引:0
|
作者
Seedorf, H
Leuwer, R
Bussopulos, A
Fenske, C
Jüde, HD
机构
[1] Univ Hamburg, Klinikum Eppendorf, Klin & Poliklin Zahn Mund & Kieferheilkunde, Abt Zahnarztliche Prothet, D-20246 Hamburg, Germany
[2] Univ Hamburg, Klinikum Eppendorf, Klin & Poliklin Hals Nasen & Ohrenheilkunde, Hamburg, Germany
[3] Univ Hamburg, Klinikum Eppendorf, Neurol Klin & Poliklin, Hamburg, Germany
来源
SCHMERZ | 2005年 / 19卷 / 01期
关键词
facial pain; orofacial pain; masticatory muscles; botulinum toxin; therapy;
D O I
10.1007/s00482-003-0296-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. Can chronic pain of the masticatory muscles be positively affected by low dose injection of botulinum toxin (BTX-A)? Methods. Twenty patients suffering chronic myofacial pain were questioned and examined after injection of 25-50 U Dysport((R)) into the affected muscles over a period of 8 weeks. Results. Four weeks after injection of BTX-A patients reported a significant reduction of pain (p < 0.001, paired t-test. Power of performed test with alpha 0,050:1.000). Then the pain remained constant over the next 4 weeks. Concurrently a significant increase of mandubular range of movement was observed (p < 0,05, Wilcoxon signed rank test). Conclusions. Even though lacking placebo control the findings suggest that patients suffering chronic myofacial pain may benefit from injection of low dose BTX-A into the affected muscles.
引用
收藏
页码:18 / +
页数:7
相关论文
共 50 条
  • [31] Botulinum toxin A in orthopedic pain therapy
    Placzek, R
    Söhling, M
    Gessler, M
    Jerosch, J
    SCHMERZ, 2004, 18 (06): : 498 - 505
  • [32] Botulinum Toxin for the Treatment of Neuropathic Pain
    Park, JungHyun
    Park, Hue Jung
    TOXINS, 2017, 9 (09):
  • [33] Botulinum toxin in the treatment of muscle pain
    Benecke, R
    Dressler, D
    Kunesch, E
    Probst, T
    SCHMERZ, 2003, 17 (06): : 450 - 458
  • [34] Botulinum toxin in specific pain therapy
    Göbel, H
    Jost, WH
    SCHMERZ, 2003, 17 (02): : 149 - 165
  • [35] Type A Botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction
    von Lindern, JJ
    ACTA NEUROLOGICA BELGICA, 2001, 101 (01) : 39 - 41
  • [36] Botulinum toxin to improve lower facial symmetry in facial nerve palsy
    Sadiq, S. A.
    Khwaja, S.
    Saeed, S. R.
    EYE, 2012, 26 (11) : 1431 - 1436
  • [37] Botulinum toxin to improve lower facial symmetry in facial nerve palsy
    S A Sadiq
    S Khwaja
    S R Saeed
    Eye, 2012, 26 : 1431 - 1436
  • [38] Botulinum Toxin for Neurogenic and Non-neurogenic Bladder Pain
    Roberts, Ly Hoang
    Gilleran, Jason P.
    CURRENT BLADDER DYSFUNCTION REPORTS, 2022, 17 (01) : 38 - 47
  • [39] Botulinum toxin A for the management of temporomandibular myofascial pain: A cohort study
    Henien, Marianne
    Mahendran, Krishantini
    Al-Sarraj, Mariam
    Rowe, Sally
    Maciag, Anna
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2025, 63 (01) : 53 - 60
  • [40] Treatment of facial myokymia in multiple sclerosis with botulinum toxin
    Mario Habek
    Ivan Adamec
    Tereza Gabelić
    Vesna V. Brinar
    Acta Neurologica Belgica, 2012, 112 : 423 - 424